SoniVie
Rosh Ha'ayin
About SoniVie
SoniVie is developing an advanced denervation solution to treat pulmonary hypertension.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $62.6M
- Funding stage: M&A
- Last round: Series C (Jan 2023)
- Website: sonivie.com
- Phone: [email protected]
Industries & Categories
Health Care, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/sonivie-17933 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.